Initial Public Offering
Baird served as co-manager on this offering.
AboutINC Research Holdings, Inc. (“INC Research” or “the Company”) (NASDAQ-GS: INCR) recently completed an initial public offering of 9,324,324 common shares at a price of $18.50 per share generating gross proceeds of approximately $172.5 million. The Company intends to use the net proceeds from the offering to redeem outstanding notes, pay redemption premiums, make-whole interest and for general corporate purposes.
INC Research is a global contract research organization providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. The Company leverages its breadth of service offerings and its depth of therapeutic expertise across multiple patient populations to connect customers, clinical research sites and patients to accelerate the delivery of new medicines to market. INC Research is headquartered in Raleigh, North Carolina.
For additional information about this transaction, please contact:
- November 2014
- INC Research Holdings, Inc.
- Target Location
- North America